Fig. 1.

Median cost per cirrhosis prevented over 10 years in Asian countries (USD in thousands). For full-paying patients, ETV had the lowest cost per cirrhosis saved at US$500,000. In Asian countries where there is partial reimbursement, ADV/LMV is the cheapest cost per cirrhosis (median) saved from patient’s perspective. For countries where there is full reimbursement, the cost per cirrhosis or HCC would be identical to full-paying patients, except that society pays for it. Median cost taken from survey on various Asian countries (Table 1). Subsidized cost = cost to patient after reimbursement, ETV = entecavir, ADV = adefovir, LMV = lamivudine, USD = United States dollars